Provent - Are you concerned about exposure to COVID-19?
Consider participating in the PROVENT study for COVID-19 prevention
The PROVENT study is investigating a combination of two experimental monoclonal antibodies for the prevention of COVID-19. The study drug has not yet been approved by regulatory authorities and can only be given to people as part of a clinical research study. You may be eligible to participate if:
- You are 18 years or older;
- You have not had a previously confirmed diagnosis of COVID-19;
- you are at higher risk of getting COVID-19 or are less likely than most adults to benefit from a vaccine (for example, because of older age, obesity or immunosuppression due to a health condition or medication).
Would you like to know more about the study?
If you would like to know more about the PROVENT study, please contact: